Supported by the W.M. Keck Foundation

What is the USC COVID-19 Biospecimen Repository (Biorepository)?

The USC COVID-19 Biospecimen Repository (Biorepository) collects blood, saliva, urine, and/or tissue samples from patients who have confirmed positive for COVID-19. The biorepository allows us to study the natural history, disease progression, and treatment response to COVID-19 in this population. Control patients are also recruited. The specimens are banked for current and future research purposes. This biorepository enables basic, translational, and clinical research in patients who have had COVID-19. 

What Are We Collecting?  

  • Blood: plasma, serum, host DNA and RNA.
  • Viral RNA
  • Saliva
  • Urine
  • Optional: tissue, CSF, bronchioalveolar lavage, tears.

Link to Detailed Schedule of Sample Collection

If you are a USC principal investigator and have additional questions on how to obtain samples from the biorepository, please contact Suail Fabros, at

NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.